hrs-9821 powder for inhalation
hrs-9821 powder for inhalation: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: West Pharmaceutical Services Inc. (WST)
Development Pipeline (1)
| Company | Phase |
|---|---|
| West Pharmaceutical Services Inc. (WST) | Phase 1 |
Clinical Trials (1)
A Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS-9821 Powder for Inhalation Administered as a Single Dose in Healthy Participants and Multiple Doses in Patients With COPD
Frequently asked questions
Who is developing hrs-9821 powder for inhalation?
hrs-9821 powder for inhalation is being developed by West Pharmaceutical Services Inc..
How many clinical trials involve hrs-9821 powder for inhalation?
BioSniper tracks 1 clinical trial involving hrs-9821 powder for inhalation.
Analyze West Pharmaceutical Services Inc. & hrs-9821 powder for inhalation with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company